Stevens-Johnson syndrome-like eruption from palbociclib in a patient with metastatic breast cancer

Theodora Karagounis; Mounica Vallurupalli; Neera Nathan; Rosalynn Nazarian; Priyanka Vedak; Laura Spring; Steven T Chen

doi:10.1016/j.jdcr.2017.12.015

Stevens-Johnson syndrome-like eruption from palbociclib in a patient with metastatic breast cancer

JAAD Case Rep. 2018 Apr 30;4(5):452-454. doi: 10.1016/j.jdcr.2017.12.015. eCollection 2018 Jun.

Authors

Theodora Karagounis¹, Mounica Vallurupalli², Neera Nathan³, Rosalynn Nazarian⁴, Priyanka Vedak³, Laura Spring⁵, Steven T Chen^{3

5}

Affiliations

¹ College of Physicians and Surgeons, Columbia University Medical Center, New York, New York.
² Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.
³ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
⁴ Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
⁵ Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.

No abstract available

Keywords: CDK, cyclin-dependent kinase; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; SJS, Stevens-Johnson syndrome; Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis; cyclin-dependent kinase 4/6 inhibitors; drug reaction; palbociclib.

Publication types

Case Reports

Grants and funding

UL1 TR001102/TR/NCATS NIH HHS/United States